[Federal Register Volume 63, Number 79 (Friday, April 24, 1998)]
[Notices]
[Page 20413]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10920]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


The Centers for Disease Control and Prevention (CDC) Announces 
the Following Meeting

    Name: Advisory Committee on Immunization Practices (ACIP) Working 
Group on Influenza.
    Times and dates: 8 a.m.-5:30 p.m., May 11, 1998; 8 a.m.-3:30 p.m., 
May 12, 1998.
    Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, CDC, 
on the appropriate uses of immunizing agents.
    Matters to be Discussed: The Influenza Working Group was formed to 
assist the Committee in expanding the current ACIP influenza 
immunization recommendations to include the use of new influenza 
vaccines and antiviral agents expected to be licensed by the Food and 
Drug Administration within the next 2 years.
    Matters to be Discussed: Agenda will include presentations on the 
potential health benefits, social and economic effects, immunologic 
effects, and concerns related to annual influenza immunization of 
healthy children; development of live attenuated influenza vaccine 
(LAIV); immunologic, virologic, and clinical studies on LAIVs; and a 
review of the safety and effectiveness of a LAIV. Other matters of 
relevance to the working group may be discussed.
    Agenda items are subject to change as priorities dictate.
    Contact person for more information: Gloria A. Kovach, Committee 
Management Specialist, CDC, 1600 Clifton Road, NE, M/S D-50, Atlanta, 
Georgia 30333, telephone 404/639-7250.

    Dated: April 20, 1998.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 98-10920 Filed 4-23-98; 8:45 am]
BILLING CODE 4163-18-P